Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm · 2022 · PMC9562042 · PMID 36229190

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep = 0.05actually significant

Only converters had annualized decrease in MV thickness before conversion to SPMS of −0.04 ± 0.01 mm 3 /y ( p = 0.001), but the difference between groups for MV change did not reach statistical significance ( p = 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.